Best et all reported 2 scores for evaluating a patient taking antithrombotic therapy for cerebrovascular disease. One score predicts intracerebral hemorrhage (ICH) and the other ischemic stroke (IS). The authors are from multiple institutions from around the world.
MICON stands for Microbleeds International Collaborative Network.
Patient selection: antithrombotic therapy for previous stroke or transient ischemic attach (TIA)
Outcome: ischemic stroke (IS)
Parameters:
(1) number of cerebral microbleeds
(2) T2* GRE (gradient-recalled echo) sequence used
(3) age in years
(4) ethnic population
(5) ischemic stroke before presenting stroke or TIA
(6) presentation with ischemic stroke
(7) diabetes mellitus
(8) antithrombotic therapy
Parameter |
Finding |
Points |
number of cerebral microbleeds |
0 |
0 |
|
1 |
1 |
|
2 to 4 |
2 |
|
5 to 19 |
4 |
|
>= 20 |
5 |
T2* GRE sequence used |
no |
0 |
|
yes |
3 |
age in years |
<60 years |
0 |
|
60 to 69 years |
1 |
|
>= 70 years |
4 |
ethnic population |
East-Asian |
4 |
|
other |
0 |
previous ischemic stroke |
no |
0 |
|
yes |
5 |
presentation with ischemic stroke |
no |
0 |
|
yes |
2 |
diabetes mellitus |
no |
0 |
|
yes |
2 |
antithrombotic therapy |
atrial fibrillation AND antiplatelet only |
9 |
|
no atrial fibrillation AND antiplatelet only |
4 |
|
atrial fibrillation and oral anticoagulant |
0 |
|
oral anticoagulant for other reason |
2 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 34
• The higher the score the greater the risk of ischemic stroke.
Performance:
• The area under the ROC curve is 0.63 (optimism-adjusted).
Specialty: Neurology